Hennessy Advisors Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.07M Buy
90,326
+30,326
+51% +$2.45M 0.23% 128
2026
Q1
$5.2M Buy
60,000
+2,100
+4% +$201K 0.19% 155
2025
Q4
$5.56M Sell
57,900
-3,300
-5% -$321K 0.2% 142
2025
Q3
$5.83M Sell
61,200
-900
-1% -$82.7K 0.2% 141
2025
Q2
$5.41M Hold
62,100
0.18% 150
2025
Q1
$5.58M Buy
62,100
+5,400
+10% +$483K 0.19% 144
2024
Q4
$4.53M Sell
56,700
-2,000
-3% -$173K 0.13% 155
2024
Q3
$5.28M Hold
58,700
0.17% 145
2024
Q2
$4.62M Sell
58,700
-1,200
-2% -$98.4K 0.17% 155
2024
Q1
$5.22M Sell
59,900
-1,700
-3% -$145K 0.22% 121
2023
Q4
$5.07M Buy
+61,600
New +$4.69M 0.26% 107

Other funds holding MDT

Hennessy Advisors Inc's MDT Position: Q2 2026 in Review

Hennessy Advisors Inc increased its Medtronic (MDT) stake by 51% in Q2 2026, buying an estimated $2.45M and bringing the position to 90,326 shares worth $7.07M. The position accounts for 0.23% of the portfolio, ranked #128.

Hennessy Advisors Inc first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. 735 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hennessy Advisors Inc held 90,326 shares of Medtronic worth $7.07M as of Q2 2026.
  • Hennessy Advisors Inc bought 30,326 Medtronic shares in Q2 2026, an estimated $2.45M.
  • Medtronic made up 0.23% of Hennessy Advisors Inc's portfolio in Q2 2026, its #128 holding.
  • Hennessy Advisors Inc first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • 735 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hennessy Advisors Inc's 13F filing for Q2 2026, filed 16 Jul 2026.